With the rapid rise in popularity of artificial intelligence (AI) across various sectors throughout the United States and the European Union (EU), particularly in drug development and health care services, law departments are initially tasked with structuring sourcing activities to establish appropriate purchasing or deployment terms and governance for these new AI models and systems.

Over the course of two webinars, Epstein Becker Green and Bird & Bird will offer practical guidance and tips for how the health care and life sciences industry can better manage this enterprise risk. The program for both webinars is detailed below.

Registration is complimentary, but pre-registration is required.

Register Now

Program: Monday, June 17, 2024

11:00–11:20 a.m. ET
Transaction support and best practices in contracting provisions for the acquisition or deployment of machine learning models

11:20–11:40 a.m. ET
Intellectual property (IP) support and training data support, as these licensing deals are rife with IP issues

11:40 a.m.–12:00 p.m. ET
Privacy and security, finding a way to comply with wide-ranging requirements at the international, national, state, and local realms

Program: Friday, June 21, 2024

11:00–11:20 a.m. ET
Due diligence considerations:

  • Positive performance of the machine learning model
  • Negative performance in areas such as discrimination and bias

11:20–11:40 a.m. ET
AI governance:

  • Guardrails that should be implemented on the use of the acquired and deployed AI
  • Corporate organizational issues and alignment with existing policies

11:40 a.m.–12:00 p.m. ET
Regulatory compliance issues in the health care sector:

  • Domain-specific regulatory requirements such as those that apply to Food and Drug Administration and EU medical devices
  • EU AI Act requirements applicable to general-purpose AI models, and high-risk uses of AI systems

June 17 Speakers

Moderated by Marc Martens and Feyo Sickinghe

June 21 Speakers

Moderated by James P. Flynn

Co-Presented By

Bird & Bird


If you have any questions, please reach out to Cat Rosario

Members of the media, please contact Lori Anger.

Event Detail

June 17 and 21, 2024
11:00 a.m. ET


Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.